Celltrion | 068270 - 流动负债

金融业

KRW

KRW 21080.38B

现金及等价物

KRW 29.65B

KRW 402.86B

KRW 5539.6B

KRW 4008.4B

KRW 171.09B

股息收益率

0.42

KRW 301.04B

KRW 374.56B

1.07K

EPS每股收益

KRW 1.55K

股本和储备

KRW 16697.75B

KRW 626.11B

债务利息支出

KRW 19B

KRW 676.66M

KRW 63.29B

KRW 43164.12B

KRW 331.35B

KRW 724.99B

KRW 301.04B

普通股股本

KRW 218.78M

50.09

KRW 14.6B

KRW 1330B

销售和管理费用

KRW 249.98B

KRW 2712.09B

贸易债权人

KRW 104.19B

应收帐款人

KRW 1507.15B

	流动负债	更改		日
Akebia Therapeutics	USD 162.94M		29.56M	2025-12
Alaunos Therapeutics	USD 813K		108K	2025-12
Avita Medical	AUD 62.68M		77K	2025-12
Celltrion	KRW 4.01T		343.96B	2025-09
Dianthus Therapeutics	USD 30.73M		6.88M	2025-12
Ionis Pharmaceuticals	USD 717M		66M	2026-03
IQVIA Holdings	USD 8.34B		170M	2025-12
Moderna	USD 2.4B		408M	2026-03
Organon & Co	USD 2.39B		289M	2025-12
Revvity	USD 1.33B		108.5M	2025-12
Tectonic Therapeutic	USD 9.67M		293K	2025-12
Viatris	USD 7.09B		269.8M	2025-12
Xeris Pharmaceuticals	USD 109.57M		6.63M	2025-12